Page last updated: 2024-09-05

beta-solamarine and Androgen-Independent Prostatic Cancer

beta-solamarine has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hann, SS; Tang, Q; Wu, J; Xiang, S; Yang, L; Zhang, Q; Zheng, F	1

Other Studies

1 other study(ies) available for beta-solamarine and Androgen-Independent Prostatic Cancer

Article	Year
Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells. Scientific reports, 2016, 11-10, Volume: 6 Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Metformin; Mice, Nude; Mucin-1; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Protein Processing, Post-Translational; RNA, Messenger; Solanaceous Alkaloids; Transcription Factor RelA; Xenograft Model Antitumor Assays	2016

Article

Year

Activation of AMPKα mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells.

Scientific reports, 2016, 11-10, Volume: 6

Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Male; Metformin; Mice, Nude; Mucin-1; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms, Castration-Resistant; Protein Processing, Post-Translational; RNA, Messenger; Solanaceous Alkaloids; Transcription Factor RelA; Xenograft Model Antitumor Assays

2016